Cristina Poveda

Has grant

Assistant Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Cristina Poveda is an Assistant Professor at Baylor College of Medicine in the United States. Her research focuses on various aspects of infectious diseases, particularly those related to Chagas disease, leishmaniasis, and ascariasis. Recent articles authored by Dr. Poveda address topics such as RNA sequence analysis in macrophages, microbiota dynamics, and the development of novel vaccine candidates.

Recent Grants

Grant: Close

Host-Microbe Interaction (HOMIN)

Open Date: 2013-04-01

Close Date: 2017-04-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Jason Kimata

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

Eva H Clark

Baylor College of Medicine

UNITED STATES

View details

Jeroen Pollet

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Rebecca Legere

Assistant Professor, Equine Internal Medicine

Texas A&M University

UNITED STATES

View details

Núria Gironès

Profesora Titular

Universidad Autónoma de Madrid

SPAIN

View details

Peter J. Hotez

Baylor College of Medicine

UNITED STATES

View details

Manuel Fresno

Full Professor

Universidad Autónoma de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cristina Poveda

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

RNA Sequence Analysis in Macrophages Infected With <i>Trypanosoma cruzi</i>: Focus on TLR2 and TLR7, Iron Metabolism, and Extracellular Matrix Biosynthesis

Different responses involving Tfh cells delay parasite-specific antibody production in <i>Trypanosoma cruzi</i> acute experimental models.

Parasite-microbiota interactions: a pathway to innovative interventions for Chagas disease, leishmaniasis, and ascariasis

Microbiota dynamics during Ascaris suum larval migration: Implications for host microbial communities in a murine model

The zebrafish as a potential model for vaccine and adjuvant development

Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate

Treatments and the Perspectives of Developing a Vaccine for Chagas Disease

Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease

Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access.

Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines.

Microbiome Alterations Driven by <i>Trypanosoma cruzi</i> Infection in Two Disjunctive Murine Models.

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells

Adaptation of Chagas Disease Screening Recommendations for a Community of At-risk HIV in the United States

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine.

Molecular Remodeling of Cardiac Sinus Node Associated with Acute Chagas Disease Myocarditis

Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi

Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy.

Collaborators (7)

Jason Kimata

Eva H Clark

Jeroen Pollet

Rebecca Legere

Núria Gironès

Peter J. Hotez

Manuel Fresno

Make your next move.

Cristina Poveda

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

RNA Sequence Analysis in Macrophages Infected With <i>Trypanosoma cruzi</i>: Focus on TLR2 and TLR7, Iron Metabolism, and Extracellular Matrix Biosynthesis

Different responses involving Tfh cells delay parasite-specific antibody production in &lt;i&gt;Trypanosoma cruzi&lt;/i&gt; acute experimental models.

Parasite-microbiota interactions: a pathway to innovative interventions for Chagas disease, leishmaniasis, and ascariasis

Microbiota dynamics during Ascaris suum larval migration: Implications for host microbial communities in a murine model

The zebrafish as a potential model for vaccine and adjuvant development

Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate

Treatments and the Perspectives of Developing a Vaccine for Chagas Disease

Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease

Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access.

Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines.

Microbiome Alterations Driven by <i>Trypanosoma cruzi</i> Infection in Two Disjunctive Murine Models.

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells

Adaptation of Chagas Disease Screening Recommendations for a Community of At-risk HIV in the United States

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine.

Molecular Remodeling of Cardiac Sinus Node Associated with Acute Chagas Disease Myocarditis

Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi

Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy.

Collaborators (7)

Jason Kimata

Eva H Clark

Jeroen Pollet

Rebecca Legere

Núria Gironès

Peter J. Hotez

Manuel Fresno

Make your next move.

Different responses involving Tfh cells delay parasite-specific antibody production in <i>Trypanosoma cruzi</i> acute experimental models.